Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
Bajema et al., medRxiv, doi:10.1101/2022.12.05.22283134
https://c19early.org/bajema.html